Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-2018

5 FDA label images from Nucare Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 2018 6

68071 2018 6
Label for Atorvastatin Calcium 80 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label states a bottle count of 60 tablets and includes imprint details: ‘APO’ on one side and ‘ATV80’ on the other. Storage instructions specify controlled temperature 59-86°F. Rx only with warnings to keep out of reach of children.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph depicting cumulative incidence (%) over time in years, comparing Atorvastatin and Placebo groups. The solid line represents Atorvastatin, while the dashed line represents Placebo. The graph shows a lower cumulative incidence for Atorvastatin compared to Placebo over approximately 3.5 years, with a hazard ratio (HR) and p-value indicated.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph comparing the cumulative hazard percentage over time (up to 5 years) between placebo and atorvastatin groups. The graph shows lower cumulative hazard for atorvastatin compared to placebo. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis represents cumulative hazard percentage. A hazard ratio (HR) with confidence interval and p-value is noted on the graph.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time (up to 5 years) between two doses of atorvastatin: 10 mg (dashed line) and 80 mg (solid line). The graph shows lower event rates with the 80 mg dose. Hazard ratio and p-value are noted on the image.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure diagram of Atorvastatin Calcium, the active ingredient in the tablet film-coated oral medication labeled by NuCare Pharmaceuticals, Inc. The figure shows the molecular structure including its calcium ion component and associated molecular features.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.